BamSEC and AlphaSense Join Forces
Learn More

Gain Therapeutics Inc. – Ownership Summary

NASDAQ: GANX    
Share price (8/17/26): $2.04    
Market cap (8/17/26): $89.0 million
Search in Documents
Key Exhibits
External Links

Insider Ownership

≥5% Ownership